Press releases
- Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
- Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
- Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
- Sarepta Therapeutics to Present at Upcoming Investor Conferences
- Sarepta Therapeutics Announces Call for Applications for the 7th Annual Route 79, The Duchenne Scholarship Program
- Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Developments
More ▼
Key statistics
On Friday, Sarepta Therapeutics Inc (S1RP34:SAO) closed at 31.89, -11.64% below its 52-week high of 36.09, set on May 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 32.13 |
---|---|
High | 32.25 |
Low | 31.87 |
Bid | 31.89 |
Offer | 32.13 |
Previous close | 32.56 |
Average volume | 441.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of May 24 2024 20:54 BST.
More ▼